All In Biotech

Drug Trial Radar · NCT04567667

Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986278 in Healthy Male Participants

Pharmacokinetics and Metabolism of [14C] BMS-986278 in Healthy Male Participants

Last checked: Nov 19, 2026Latest source record: Jun 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

9

Actual

Start

Oct 15, 2020

Primary completion

Apr 11, 2021

Study completion Apr 11, 2021

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Sep 28, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 21 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the way the body absorbs, distributes, breaks down and eliminates radioactive BMS-986278 as well as the safety and tolerability of BMS-986278 in healthy male participants.

Conditions

  • Healthy Volunteers

Interventions

  • [14C] BMS-986278Drug

    Specified dose on specified days

  • Kinevac®Drug

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum observed plasma concentration (Cmax) of BMS-986278Time frame: Up to 15 days
  2. Maximum observed plasma concentration (Cmax) of total radioactivity (TRA)Time frame: Up to 15 days
  3. Time of maximum observed plasma concentration (Tmax) of BMS-986278Time frame: Up to 15 days
  4. Time of maximum observed plasma concentration (Tmax) of TRATime frame: Up to 15 days
  5. Area under the plasma concentration-time curve extrapolated to infinity (AUC(INF)) of BMS-986278Time frame: Up to 15 days
  6. Area under the plasma concentration-time curve extrapolated to infinity (AUC(INF)) of TRATime frame: Up to 15 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Covance - Clinical Pharmacology Services - Madison

    Madison, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.